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Abstract
Magnetic Resonance arthrography is considered the gold standard imaging technique for the study
of shoulder instability and tendon tears.
We describe an image artefact, characterized by decreased signal intensity of the paramagnetic
gadolinium chelate contrast agent during a shoulder Magnetic Resonance arthrography, attributable
to an incorrect concentration which does not cause evident capsular damage and is completely
absorbed after 48 h from the administration.
Background
Magnetic resonance (MR) arthrography is the gold stand-
ard imaging diagnostic technique for shoulder joint exam-
ination, mainly in the detection of elementary lesions
causing shoulder instability and tendon tears [1].
The first time of this technique consists in arthrography
with direct injection of contrast agent into the joint with
or without fluoroscopic guidance. In the second time of
the procedure, MR examination is performed by various
sequences, orientated on axial, oblique coronal and sagit-
tal planes.
The paramagnetic contrast agent used commonly is the
dimeglumine salt of gadopentetate acid (Gd-DTPA) in
different dilutions with saline solution.
During MR arthrography of the shoulder, we found an
image artefact, characterized by decreased signal intensity
of the contrast agent injected into the joint, caused by
incorrect concentration.
To the best of our knowledge such an effect, using para-
magnetic contrast agent not diluted with iodinated con-
trast solution in MR arthrography of the shoulder, has not
been reported in vivo yet.
Case presentation
A 39-year-old Caucasian male, complaining about
chronic non traumatic shoulder pain, with non-signifi-
cant radiological and ultrasound examinations, was
referred to our department to perform MR arthrography.
Our protocol includes the use of pre-filled syringes con-
taining dimeglumine salt of gadopentetate acid diluted in
saline solution (0.9% sodium chloride) at 2 mmol/l con-
centration (Magnevist© 2 mmol/l, Schering, Berlin, Ger-
many).
After the patient had signed informed consent, we per-
formed the first time of the examination injecting contrast
agent by anterior approach to shoulder joint, without
fluroscopic guidance; we injected 20 cc of contrast agent
Published: 14 December 2009
Cases Journal 2009, 2:9320 doi:10.1186/1757-1626-2-9320
Received: 18 September 2009
Accepted: 14 December 2009
This article is available from: http://www.casesjournal.com/content/2/1/9320
© 2009 Genovese et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
&DVHV-RXUQDO 2009, :9320 http://www.casesjournal.com/content/2/1/9320
Page 2 of 4
SDJHQXPEHUQRWIRUFLWDWLRQSXUSRVHV
and we found an increased resistance at capsular filling
during the administration.
In the second time of our MR arthrography protocol, we
performed, with a surface coil, SE T1-weighted sequences
on axial, oblique coronal and sagittal plane, and a TSE T2/
PD sequence with fat saturation technique on oblique
coronal plane, using a Intera Tomograph 1,5-Tesla
(Philips, Koninklijke, Netherlands).
The SE T1-weighted sequence on oblique coronal plane is
useful to display that contrast intra-articular injection is
technically correct, showing capsular filling and not con-
trast agent in the peri-articular soft tissues. On the con-
trary, we found out an image artefact characterized by
signal absence in the contrast solution injected in the
shoulder, instead of the hyperintensity of contrast signal
expected in ideal conditions (Figure 1).
Our examination did not cause immediate or late side
effects and the patient did not complain about any
decrease of shoulder motility or increase of pain.
Another MR arthrography was then performed about 48 h
later using pre-filled syringes containing dimeglumine salt
of gadopentetate acid diluted in saline solution (0.9%
sodium chloride) at 2 mmol/l concentration as our proto-
col includes.
The new examination showed the expected hyperintensity
of contrast agent signal (Fig. 2) as in ideal conditions and
the disappearance of the previous image artefact charac-
terized by signal absence. We were then able to evaluate
intra-articular structures and to answer clinical question,
detecting supraspinatus tendon partial tear on articular
side and fibrous thickening of the capsular wall of the axil-
lary pouch, as a sign of adhesive capsulitis (Figure 2), The
Proton Density Fat Saturation weighted sequence
Supraspinatus confirmed tendon partial tear (Figure 3).
Our revision of the first MR arthography procedure dis-
closed that human mistake occurred in the choice of con-
trast agent solution; in fact, a pre-filled syringe with
dimeglumine salt of gadopentetate acid diluted in saline
solution (0.9% sodium chloride) at 0.5 mol/l concentra-
tion had been accidentally used. This error was facilitated
by an external similarity of the two syringes.
SE T1-weighted sequence (TR/TE/Thick: 500 ms/10 ms/4 mm) on oblique coronal plane after administration of dimeg-lu ine salt of gad pe tetate acid diluted in saline s lution at 0.5 m l/l concentratioFigure 1
SE T1-weighted sequence (TR/TE/Thick: 500 ms/10 
ms/4 mm) on oblique coronal plane after administra-
tion of dimeglumine salt of gadopentetate acid 
diluted in saline solution at 0.5 mol/l concentration. 
Artefact is detectable, characterized by contrast signal 
absence (black arrows), with no evidence of contrast agent in 
peri-articular soft tissues.
SE T1-weighted sequence (TR/TE/Thick: 500 ms/10 ms/4 mm) on oblique coronal plane, after administration of dimeg-lu ine salt of gad pe tetate acid diluted i  saline solution at 2 m l/l concentratioFigure 2
SE T1-weighted sequence (TR/TE/Thick: 500 ms/10 
ms/4 mm) on oblique coronal plane, after adminis-
tration of dimeglumine salt of gadopentetate acid 
diluted in saline solution at 2 mmol/l concentration. 
The expected contrast signal hyperintensity is detectable 
(black arrows). Capsular wall fibrous thickening at axillary 
pouch (white arrows) and supraspinatus tendon partial tear 
on articular side (point white arrow) are evident.
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No immediate or late side effects occurred even after the
second MR arthrography.
Discussion
Shoulder MR arthography is characterized by higher sen-
sitivity than non enhanced MR in the detection of elemen-
tary lesions of rotator cuff tendons and capsulo-
legamentous structures [1].
MR arthrography is performed with anterior approach to
shoulder joint under fluoroscopic guidance or without it
and the choice of the site of injection is made with specific
anatomic criteria. Fluoroscopic guidance requires the
addition of non ionic iodinated contrast solution to para-
magnetic contrast agent to detect intra-articular place-
ment of the needle [2]; on the contrary, in the procedure
without fluorscopic guidance, such a solution is not nec-
essary [3].
In our protocol we use pre-filled syringes with Gd-DTPA
solution at 2 mmol/l concentration. In vitro studies [3]
show that this is the ideal paramagnetic contrast agent
concentration in order to evaluate the anatomic structures
we aim to study. Paramagnetic contrast agents display a
biphasic behaviour, with high signal/noise rate in T1
relaxation time and decrease in T2 relaxation time because
the agents generally reduce the relaxation times of the tis-
sues. In vitro studies show that even small amounts of
iodinated contrast agents decrease significantly paramag-
netic contrast intensity [2,3]. Such an effect was reported
also in vivo [4].
In our case, Magnetic Resonance Imaging (MRI) obtained
after paramagnetic contrast solution administration, with-
out iodinated contrast agent, showed unusual contrast
signal behaviour, characterized by signal absence in SE
T1-weighted sequence. After a careful revision of the pro-
cedure, we detected a mistake in the choice of the pre-
filled syringe, as a contrast solution prepared for intra-vas-
cular administration and not for intra-articular injection
was used.
The two solutions contained the same components at dif-
ferent concentration; in fact, the intra-articular contrast
agent we used was at 2 mmol/l concentration while the
one accidentally used in our case was at higher concentra-
tion and this provides a prevalent effect on T2 relaxation
time, a rare event after intravenous injection, due to the
dilution in the blood stream. Therefore the signal altera-
tion described was caused by the abnormally high Gd-
DTPA concentration and not by the presence of iodinated
contrast, as reported by Montgomery and coll [4]. Aydin-
goz et al [5] described a similar signal alteration during a
MR arthrography of the hip performed using an accidental
excessive amount of gadolinium chelates diluted with
saline solution and local anesthetic.
The combination with other substances could not influ-
ence the image artefact, as the Authors suppose, because
we demonstrated that the local anesthetic acts like saline
solution when it is mixed with Gd-DTPA [3]. So, we agree
with the Authors when they state that another possible
explanation could be the excessive intra-articular admin-
istration of the paramagnetic contrast agent.
In the case reported no immediate or late side effects
occurred after high concentration of paramagnetic con-
trast administration: therefore we confirm that paramag-
netic contrast does not cause clinically evident side effects
as at dilution commonly used [6] as at the concentration
routinely injected intravenously.
The subsequent MR arthrography performed in our case
shows that the whole amount of contrast agent injected
was absorbed by joint synovial tissue, with no contrast
left-over.
We noticed an increased resistance at capsular filling dur-
ing contrast solution administration and it was con-
firmed, even if less remarkable, in the subsequent MR
Proton Density FS-weighted sequence (TR/TE/Thick: 4011 ms/7,272 ms/4 mm) on obliqu  coronal plane, after adminis-trati of dimeglumine salt of gadopentetate acid diluted in saline s lution at 2 mmol/l concentrationFigure 3
Proton Density FS-weighted sequence (TR/TE/Thick: 
4011 ms/7,272 ms/4 mm) on oblique coronal plane, 
after administration of dimeglumine salt of gadopen-
tetate acid diluted in saline solution at 2 mmol/l con-
centration. Supraspinatus tendon partial tear on articular 
side was confirmed (point white arrow).
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arthography. This can be only partly justified by the differ-
ent viscosity characterizing the two solutions; [2] in fact,
in the following MR arthography we detected signs inter-
preted as adhesive capsulitis with decreased filling of the
axillary pouch.
Conclusion
In conclusion, intra-articular paramagnetic contrast agent
not diluted with iodinated contrast solution does not
cause evident capsular damage and is completely
absorbed after 48 h from the administration.
Abbreviations
Gd-DTPA: gadolinium diethylenetriamine penta-acetic
acid; MR: magnetic resonance.
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